Lanean...

The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas

Prolactinomas are the most frequently observed pituitary adenomas and most of them respond well to conventional treatment with dopamine agonists. However, a subset of prolactinomas fails to respond to such therapies and is considered as dopamine agonist-resistant prolactinomas (DARPs). New therapeut...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Endocrinol
Egile Nagusiak: Recouvreux, M. Victoria, Camilletti, M. Andrea, Rifkin, Daniel B., Díaz-Torga, Graciela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760866/
https://ncbi.nlm.nih.gov/pubmed/26698564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JOE-15-0451
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!